342 related articles for article (PubMed ID: 24830593)
1. An overview on the treatment of postmenopausal osteoporosis.
Maeda SS; Lazaretti-Castro M
Arq Bras Endocrinol Metabol; 2014 Mar; 58(2):162-71. PubMed ID: 24830593
[TBL] [Abstract][Full Text] [Related]
2. Preventing osteoporosis-related fractures: an overview.
Gass M; Dawson-Hughes B
Am J Med; 2006 Apr; 119(4 Suppl 1):S3-S11. PubMed ID: 16563939
[TBL] [Abstract][Full Text] [Related]
3. Antifracture efficacy of currently available therapies for postmenopausal osteoporosis.
Reginster JY
Drugs; 2011 Jan; 71(1):65-78. PubMed ID: 21175240
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Pharmacological Therapies for the Prevention of Fractures in Postmenopausal Women: A Network Meta-Analysis.
Barrionuevo P; Kapoor E; Asi N; Alahdab F; Mohammed K; Benkhadra K; Almasri J; Farah W; Sarigianni M; Muthusamy K; Al Nofal A; Haydour Q; Wang Z; Murad MH
J Clin Endocrinol Metab; 2019 May; 104(5):1623-1630. PubMed ID: 30907957
[TBL] [Abstract][Full Text] [Related]
5. Current and emerging pharmacologic therapies for the management of postmenopausal osteoporosis.
Lewiecki EM
J Womens Health (Larchmt); 2009 Oct; 18(10):1615-26. PubMed ID: 19857095
[TBL] [Abstract][Full Text] [Related]
6. Strategies for the prevention and treatment of osteoporosis during early postmenopause.
Delaney MF
Am J Obstet Gynecol; 2006 Feb; 194(2 Suppl):S12-23. PubMed ID: 16448872
[TBL] [Abstract][Full Text] [Related]
7. Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society.
Menopause; 2010; 17(1):25-54; quiz 55-6. PubMed ID: 20061894
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis.
Iwamoto J; Takeda T; Sato Y
Curr Med Res Opin; 2006 May; 22(5):919-28. PubMed ID: 16709313
[TBL] [Abstract][Full Text] [Related]
9. Management of postmenopausal osteoporosis and the prevention of fractures.
Gambacciani M; Levancini M
Panminerva Med; 2014 Jun; 56(2):115-31. PubMed ID: 24942322
[TBL] [Abstract][Full Text] [Related]
10. EMAS clinical guide: selective estrogen receptor modulators for postmenopausal osteoporosis.
Palacios S; Brincat M; Erel CT; Gambacciani M; Lambrinoudaki I; Moen MH; Schenck-Gustafsson K; Tremollieres F; Vujovic S; Rees M; Rozenberg S
Maturitas; 2012 Feb; 71(2):194-8. PubMed ID: 22176952
[TBL] [Abstract][Full Text] [Related]
11. How to manage postmenopausal osteoporosis?
Body JJ
Acta Clin Belg; 2011; 66(6):443-7. PubMed ID: 22338309
[TBL] [Abstract][Full Text] [Related]
12. Treatment and prevention of osteoporosis.
Blahos J
Wien Med Wochenschr; 2007; 157(23-24):589-92. PubMed ID: 18204959
[TBL] [Abstract][Full Text] [Related]
13. [Therapy of osteoporosis: bisphosphonates, SERM's, teriparatide and strontium].
Uebelhart D; Frey D; Frey-Rindova P; Goerres G; Michel BA
Z Rheumatol; 2003 Dec; 62(6):512-7. PubMed ID: 14685711
[TBL] [Abstract][Full Text] [Related]
14. Postmenopausal osteoporosis: Assessment and management.
Rizzoli R
Best Pract Res Clin Endocrinol Metab; 2018 Oct; 32(5):739-757. PubMed ID: 30449552
[TBL] [Abstract][Full Text] [Related]
15. Developments in the pharmacotherapeutic management of osteoporosis.
Close P; Neuprez A; Reginster JY
Expert Opin Pharmacother; 2006 Aug; 7(12):1603-15. PubMed ID: 16872263
[TBL] [Abstract][Full Text] [Related]
16. [Absolute risk for fracture and WHO guideline. Selection of drugs for the prevention of fractures in postmenopausal women].
Gorai I;
Clin Calcium; 2007 Jul; 17(7):1090-6. PubMed ID: 17607077
[TBL] [Abstract][Full Text] [Related]
17. Update on osteoporosis therapy.
Borges JL; Bilezikian JP
Arq Bras Endocrinol Metabol; 2006 Aug; 50(4):755-63. PubMed ID: 17117300
[TBL] [Abstract][Full Text] [Related]
18. Update of current therapeutic options for the treatment of postmenopausal osteoporosis.
Epstein S
Clin Ther; 2006 Feb; 28(2):151-73. PubMed ID: 16678639
[TBL] [Abstract][Full Text] [Related]
19. [Update on treatment of postmenopausal osteoporosis].
Body JJ
Rev Med Brux; 2008 Sep; 29(4):301-9. PubMed ID: 18949981
[TBL] [Abstract][Full Text] [Related]
20. What is the best balance of benefits and risks among anti-resorptive therapies for postmenopausal osteoporosis?
Miller PD; Derman RJ
Osteoporos Int; 2010 Nov; 21(11):1793-802. PubMed ID: 20309524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]